Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O’Keefe

Ceribell announced the appointment of Thomas West and Sharon O'Keefe to its Board of Directors. West, former CEO of Nalu Medical (acquired by Boston Scientific for $600M) and Intersect ENT (acquired by Medtronic for $1.1B), and O'Keefe, former President of University of Chicago Medical Center, bring significant commercial and health-system leadership experience. The appointments support Ceribell's expansion as its point-of-care brain monitoring platform is now deployed in over 680 U.S. hospitals.

07/29/2026, 7:00 AM • GlobeNewswire

Implicity’s Next-Generation ILR ECG Analyzer Earns FDA Clearance

Implicity announced FDA 510(k) clearance for its next-generation ILR ECG Analyzer, a cloud-based AI software that reduces false-positive alerts from implantable cardiac monitors by up to 76% while maintaining high sensitivity. The manufacturer-agnostic algorithm works with devices from Abbott, Biotronik, Boston Scientific, and Medtronic, addressing a significant clinical workflow burden in remote cardiac monitoring.

07/28/2026, 7:45 AM • GlobeNewswire

Electrosurgery Market Projected to Reach $11.59 Billion by 2031 as Demand for Minimally Invasive Procedures Rises - Analysis by Product, Surgery, End User and Region

The global electrosurgery market is projected to grow from $8.01 billion in 2025 to $11.59 billion by 2031, with a CAGR of 6.4%. Growth is driven by increasing surgical volumes, rising chronic disease prevalence, and adoption of minimally invasive procedures. However, challenges include procedural risks, regulatory constraints, and surgeon shortages. Ambulatory surgical centers are expanding their role, while the United States leads North American growth.

07/24/2026, 10:41 AM • GlobeNewswire

Global Robotic Endoscopy Devices Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~10% by 2034 | DelveInsight

The global robotic endoscopy devices market is projected to grow from USD 2.8 billion in 2025 to USD 6.5 billion by 2034, driven by increasing demand for minimally invasive procedures, technological advancements in AI-enabled navigation and imaging, and rising prevalence of gastrointestinal disorders. North America leads the market with 42% share, while Asia-Pacific is expected to witness the highest growth. Key players include Intuitive Surgical, Medtronic, Johnson & Johnson MedTech, and others.

07/22/2026, 1:00 PM • GlobeNewswire

Urology Devices Market Size to Reach USD 80.0 Billion by 2035 | SNS Insider

The global urology devices market is valued at USD 39.23 billion in 2025 and is projected to reach USD 80.0 billion by 2035, growing at a CAGR of 7.35%. Growth is driven by rising demand for robotic-assisted surgery, kidney disease treatment, and minimally invasive procedures. North America leads the market while Asia Pacific records the fastest growth.

07/20/2026, 7:53 AM • GlobeNewswire

Disposable Endoscopes Market Size Projected to Hit USD 10.47 Billion by 2035 | SNS Insider

The global disposable endoscopes market is expected to expand at a CAGR of 15.04% through 2035, driven by rising infection prevention initiatives, adoption of single-use endoscopes, and minimally invasive procedures. North America leads with 38.45% market share, while Asia Pacific records the fastest growth. Hospitals dominate the end-user segment with 55.36% market share, with ambulatory surgical centers showing the highest growth potential.

07/13/2026, 11:00 AM • GlobeNewswire

Brain Implants Market Size to Reach USD 18.39 Billion by 2035, Growing at 9.99% CAGR | SNS Insider

The global brain implants market, valued at USD 7.10 billion in 2025, is projected to reach USD 18.39 billion by 2035, growing at a CAGR of 9.99%. Growth is driven by rising prevalence of neurological disorders and increasing adoption of deep brain stimulation, neuromodulation systems, and brain-computer interfaces. North America leads the market, with the U.S. expected to grow from USD 3.16 billion to USD 8.17 billion by 2035.

06/27/2026, 4:30 AM • GlobeNewswire

Microcatheter Market Size to Reach USD 1.79 Billion by 2035 | SNS Insider

The global microcatheter market is valued at USD 1.05 billion in 2025 and is projected to reach USD 1.79 billion by 2035, expanding at a CAGR of 5.53%. Growth is driven by increasing adoption of minimally invasive cardiovascular and neurovascular procedures, rising prevalence of cardiovascular and neurovascular disorders, and advancements in catheter technologies. Aspiration microcatheters lead with 36% market share, while steerable microcatheters are the fastest-growing segment. North America dominates with 34% of global revenues, with Asia-Pacific emerging as the fastest-growing region.

06/19/2026, 5:09 AM • GlobeNewswire

Meet the Medtech Stock Wall Street Thinks Will Soar 65% Over the Next 12 Months

Boston Scientific shares have plummeted over 50% year-to-date due to repeated downward guidance revisions, particularly regarding declining Watchman procedure usage. Despite bearish market sentiment, 27 of 31 analysts maintain buy ratings with a consensus price target of $78 (65% upside), though the article cautions this recovery may be challenging without faster-than-expected growth acceleration.

06/13/2026, 12:15 AM • The Motley Fool

Peripheral Vascular Devices Market by Type, End User - Global Forecast to 2031

The global peripheral vascular devices market is projected to grow from USD 10.02 billion in 2026 to USD 13.22 billion by 2031 at a CAGR of 5.7%, driven by rising prevalence of vascular disorders, aging populations, and innovations in minimally invasive devices. Asia Pacific is expected to see the highest growth, with major players including Boston Scientific, Medtronic, and Abbott leading the market.

06/02/2026, 4:49 AM • GlobeNewswire

Zscaler, AutoZone, And Regencell Are Among Top 10 Large-Cap Losers Last Week (May 25-May 29): Are The Others In Your Portfolio?

Ten large-cap stocks experienced significant declines during the week of May 25-29, 2026. Zscaler led losses with a 20.06% drop following disappointing Q3 results and weak Q4 guidance. Other major losers included Boston Scientific (16.95%), AutoZone (14.21%), Regencell Bioscience (12.61%), and Venture Global (10.87%). Declines were attributed to earnings misses, analyst downgrades, and energy sector weakness following geopolitical developments.

05/31/2026, 9:49 AM • Benzinga

Boston Scientific Is Betting $1.5 Billion on a Massive Market -- and Wall Street Is Paying Attention

Boston Scientific announced a $1.5 billion investment for a 34% stake in MiRus LLC, gaining entry into the transcatheter aortic valve replacement (TAVR) market projected to grow from $4.5 billion in 2024 to $12.2 billion by 2033. The deal includes an option to acquire the remaining stake for up to $3 billion if milestones are met. Wall Street remains bullish with 92% of analysts rating the stock a buy, while insider buying and a $2 billion share buyback signal management confidence.

05/27/2026, 2:15 PM • The Motley Fool

Dow Jones Hit Records Above 50,600 As Oil Sinks Below $90: Stock Market Today

The Dow Jones Industrial Average reached a record high above 50,600 while the Nasdaq 100 declined 0.7% on Wednesday. Oil prices fell sharply below $90 per barrel following reports of potential Iran negotiations, benefiting travel and leisure stocks. The S&P 500 edged slightly lower as semiconductor stocks retreated, while consumer discretionary and hospitality sectors led gains.

05/27/2026, 1:29 PM • Benzinga

Boston Scientific Advances Coronary Calcium Treatment With Positive Trial Results

Boston Scientific reported positive pivotal trial results for its SEISMIQ 4CE Coronary Intravascular Lithotripsy catheter, meeting both primary safety and effectiveness endpoints in patients with severely calcified coronary artery disease. The trial of 420 patients achieved a 93.3% safety rate and 93.7% procedural success rate, exceeding pre-specified benchmarks. The device uses laser-generated acoustic pressure waves to fracture calcium buildup in coronary arteries before stent implantation.

05/19/2026, 12:01 PM • Benzinga

Boston Scientific Targets Growing Aortic Stenosis Market With $1.5 Billion Deal

Boston Scientific invested $1.5 billion in MiRus to acquire a 34% equity stake and exclusive option to acquire the SIEGEL Balloon Expandable TAVR system for treating severe aortic stenosis. The investigational device features a smaller delivery profile and advanced materials. Boston Scientific shares surged 5.56% on the announcement, though the stock remains down 42% year-to-date.

05/18/2026, 2:40 PM • Benzinga